Regulatory compliance – Page 34

Record retention failures during validation lifecycle – CAPA and revalidation strategy

Addressing Record Retention Failures in the Validation Lifecycle and Developing a CAPA Strategy Record retention failures during the validation lifecycle are a pressing concern for pharmaceutical professionals. From production to…

CSV compliance weak during inspection readiness – risk-based validation alignment

Enhancing CSV Compliance for Inspection Readiness in Pharmaceutical Manufacturing In the pharmaceutical sector, the robust execution of Computerized System Validation (CSV) is crucial, particularly during inspection periods. A weak CSV…

Hybrid paper-electronic workflows uncontrolled during system operation – 21 CFR Part 11 compliance gaps

Uncontrolled Hybrid Paper-Electronic Workflows: Compliance Gaps and Resolutions In today’s pharmaceutical landscape, the convergence of paper and electronic workflows presents unique challenges regarding compliance with 21 CFR Part 11. Pharmaceutical…

Validation gaps identified during lifecycle management – risk-based validation alignment

Addressing Validation Gaps in Lifecycle Management for Regulatory Compliance In today’s complex pharmaceutical manufacturing landscape, identifying validation gaps during lifecycle management is crucial for maintaining regulatory compliance. Such gaps can…

Hybrid paper-electronic workflows uncontrolled during system upgrade – preventing repeat Part 11 findings

Managing Uncontrolled Hybrid Paper-Electronic Workflows During System Upgrades The rapid digital transformation in pharmaceutical operations has fostered hybrid workflows that combine paper and electronic systems. However, improperly managed transitions can…

Validation gaps identified during site expansion – risk-based validation alignment

Addressing Validation Gaps During Site Expansion: A Comprehensive Playbook In the dynamic environment of pharmaceutical manufacturing, site expansions can pose significant challenges, particularly when it comes to maintaining compliance with…

Hybrid paper-electronic workflows uncontrolled during validation lifecycle – preventing repeat Part 11 findings

Managing Uncontrolled Hybrid Paper-Electronic Workflows During Validation to Prevent Part 11 Findings In the rapidly evolving landscape of pharmaceutical manufacturing and regulatory compliance, addressing the challenges posed by hybrid paper-electronic…

Validation gaps identified during site expansion – CAPA and revalidation strategy

Addressing Validation Gaps Encountered During Site Expansion: A Hands-On CAPA and Revalidation Guide Validation gaps often emerge during a site expansion project, potentially jeopardizing compliance and product quality. For pharmaceutical…

Record retention failures during compliance audit – preventing repeat Part 11 findings

Preventing Repeat Findings from Record Retention Failures in Compliance Audits During compliance audits, record retention failures can trigger non-compliance issues, particularly related to 21 CFR Part 11 regarding electronic records.…

Validation gaps identified during change control – risk-based validation alignment

Mitigating Validation Gaps Found During Change Control: A Comprehensive Playbook Validation gaps identified during change control can lead to significant compliance and quality issues in pharmaceutical manufacturing. They often result…

System access controls weak during validation lifecycle – preventing repeat Part 11 findings

Strengthening System Access Controls Throughout the Validation Lifecycle Pharmaceutical companies often face challenges related to system access controls, particularly during the validation lifecycle. Weak access controls can lead to significant…

CSV compliance weak during lifecycle management – risk-based validation alignment

Enhancing CSV Compliance Throughout Lifecycle Management for Regulatory Readiness Pharmaceutical manufacturing often grapples with the challenge of maintaining compliance in computer system validation (CSV) during the lifecycle of software and…